Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 392 of 673

Advanced search

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

PharmaTher Collaborates with Craft Health to Evaluate CraftMake(TM) GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides

newsfilecorp.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Is Teva Pharmaceutical Industries Ltd (TEVA) Facing Challenges A

GuruFocusOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

PCSA Stock Jumps As Traders Pile Into Biotech Micro-Cap

StocksToTradeOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

How Collegium's Quarterly Beat but Softer Outlook Could Reframe Collegium Pharmaceutical (COLL) Investors

simplywall.stOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

(TEVA) Teva Pharmaceutical Expects 2026 Adjusted EPS Range $1.91 - $2.11

marketscreener.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech: International Expansion And A Vibrant Pipeline (NASDAQ:KRYS)

Seeking AlphaOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center

The Manila TimesOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies

The Manila TimesOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Struggling Sarepta Therapeutics appoints former AbbVie executive as savior

medwatch.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

A one-time treatment for geographic atrophy gains FDA RMAT status

Stock TitanOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Silexion Therapeutics Successfully Initiates Phase 2/3

GlobeNewswireOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Silexion Opens Its First Pancreatic Cancer Trial Site in Israel

Stock TitanOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

PBS Biotech Joins Organoid COMMONS to Accelerate Industrialization and Scalability of Human-Relevant Models

PR NewswireOriginal source

🇺🇸Jul 29Devicesinvestors.bd.comTier 1 · Company source

EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

Becton Dickinson (BD)Original source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Mutation in Rice Protein Kinase Leads to Drought Tolerance

ISAAA.orgOriginal source

🇺🇸Jul 29Devicesnews.bostonscientific.comTier 1 · Company source

Boston Scientific announces results for second quarter 2026

Boston Scientific NewsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

After Nearly a Decade-Long Decrease, Testosterone Prescribing Rates Rising Again

Epic ResearchOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) Stock May Be Cheap After CEO Resignation

Yahoo FinanceOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

June M&A recap: Three deals, three billion-dollar stories

Drug Discovery NewsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Why Chinese Biotech Licensing Deals Became Attractive to US Investors

Pharmaceutical ExecutiveOriginal source

🇺🇰Jul 29Regulatorygov.ukTier 1 · Regulatory source

Respiratory syncytial virus (RSV) maternal vaccination coverage in England: March 2026

Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination p...

UK Health Security AgencyOriginal source

🇺🇰Jul 29Regulatorygov.ukTier 1 · Regulatory source

Respiratory syncytial virus (RSV) older adults vaccination coverage in England: June 2026

Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination p...

UK Health Security AgencyOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Biotech academy gets nearly $500k for Boston expansion location

Gloucester Daily TimesOriginal source

🌍Jul 29Regulatoryinfarma.plTier 1 · Regulatory source

Zmiany tak, ale w dialogu i likwidujące bariery

INFARMA PolandOriginal source

🇩🇪Jul 29Researchuni-heidelberg.deTier 2 · Direct publisher

Ceremonial Conclusion of Vocational Training

Heidelberg UniversityOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Tasrif Pharmaceutical Announces Grant of Second U.S. Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor (CD155)

The Manila TimesOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech: Profitable, Self-Funding, And Loaded With Optionality (NASDAQ:KRYS)

Seeking AlphaOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Tasrif Pharmaceutical Announces Grant of Second U.S. Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor (CD155)

Yahoo FinanceOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Czechia looks to Irish EU presidency to advance Biotech Act

euractiv.comOriginal source

🇺🇰Jul 29Regulatorygov.ukTier 1 · Regulatory source

Vaccine update: issue 373, July 2026

Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.

UK Health Security AgencyOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

PNC Financial Services Group Inc. Has $2.88 Million Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🇺🇰Jul 29Industrygsk.comTier 1 · Company source

Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

GSK NewsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Is VR training for pharmaceutical manufacturing a reality? — Founder gives peek behind the curtain

Cleanroom TechnologyOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

What Trump’s 200% tariff threat on generics means to pharmaceutical industry

Pinsent MasonsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Novo Pharmatech CEO: Rapid change in the pharmaceutical industry is placing new demands on management

medwatch.comOriginal source

🌍Jul 29discoverynews.google.comTier 2 · Trade media

The VA could help America win the biotechnology race with China

STATOriginal source

🌍Jul 29discoverynews.google.comTier 2 · Trade media

In the biotech industry, a most-wanted fugitive was long hiding in plain sight

STATOriginal source

🇺🇰Jul 29Regulatorygov.ukTier 1 · Regulatory source

Communicable disease outbreak management guidance

Identification and management of outbreaks and resources to support local health protection system r...

UK Health Security AgencyOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Does Legend Biotech’s (LEGN) CEO Exit Reshape Confidence In Its Cell Therapy Expansion Strategy?

simplywall.stOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRX

RTTNewsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Regulatory round-up: 29 July 2026

The Pharma LetterOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Lushang Freda Pharmaceutical Co., Ltd. Class A – SSE:600223

TradingViewOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

RTW Biotech's Portfolio Company Completes Merger with Vyne Therapeutics

marketscreener.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Paradigm (ASX:PAR) Reaches 50% Enrolment in Phase 3 Osteoarthritis Trial - Will Interim Analysis Be Its Defining Moment?

KalkineOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

AIDS 2026: Some pieces falling into place for monthly HIV prevention pill, but key data not yet in

spotlightnsp.co.zaOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Mumbai's elite clubs under scanner: FDA suspends food licences of five iconic clubs over serious hygiene violations

WIONOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by ADAR1 Capital Management LLC

MarketBeatOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

12 Funding Rounds That Show Where APAC Biotech Capital Is Going

BioPharma APACOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Veru Completes Enrollment in Phase 2b PLATEAU Trial of Enobosarm and Semaglutide

The Clinical Trial VanguardOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Atea’s Bemnifosbuvir/Ruzasvir Meets Endpoints in Phase 3 Hepatitis C Trial

The Clinical Trial VanguardOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Long COVID’s Phase 3 Reckoning: What STIMULATE-ICP Reveals About Designing Trials for Diseases Medicine Can’t Yet Explain

The Clinical Trial VanguardOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Bacchus sales lift Dong-A Socio Holdings to record Q2 revenue

koreabiomed.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Ingenia Therapeutics sets IPO price at ₩12,000

koreabiomed.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Hanmi Pharm's Q2 operating profit doubles on Rosuzet growth, Eli Lilly licensing deal

koreabiomed.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) CEO Exit Tests Management Stability Around Its CAR-T Multiple Myeloma Strategy

Yahoo FinanceOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

AIDS activists slam pharmaceutical companies’ greed over HIV drug

New Age BDOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Blister Packaging Market Expands as Pharmaceutical Demand and Sustainable Innovation Drive Global Growth

EIN NewsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

5 Mumbai clubs face food safety action: FDA releases pics, list of violations

India TodayOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Ingenia Therapeutics sets IPO price at ₩12,000

koreabiomed.comOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) Sees Large Growth in Short Interest

MarketBeatOriginal source